Stents and endovascular grafts represent a large and growing segment of the medical
device market, as well as an area of significant technological change. Important growth
segments in this market include coronary stents, carotid and renal stents, and endo-
vascular grafts. The market has historically been highly dynamic, and characterized by
rapid changes in market share driven by technology and intellectual property factors.
Most of the major suppliers in the medical device industry participate in the market, and
companies must base their investment decisions in this area on a sound understanding
of the market's dynamics and competitive factors. This report also includes data on the
global vascular graft products market, data that is typically not found in reports from
other suppliers.
Report #376 - Global Markets for Stents and Vascular Grafts, 2002-2008
CONTENTS
EXECUTIVE SUMMARY
1. END-USER ENVIRONMENT
1.1 Global Cardiovascular Disease Trends
1.2 Trends in the Number of Facilities Performing Vascular and Endovascular Therapy
1.2.1 Catheterization Laboratories
1.2.2 Vascular Surgery Centers
1.3 Trends in Outpatient Procedures and Procedure Site Shifts
1.4 Trends in Health Care Costs and Reimbursement for Vascular and Endovascular
Therapy
2. CLINICAL OVERVIEW AND PROCEDURE VOLUME FORECAST
2.1 Coronary Stents
2.1.1 Disease Incidence and Indications for Use of Coronary Stents
2.1.2 Procedure Volumes for Coronary Stents
2.1.3 Clinical Status and Outcomes Data for Coronary Stents
2.2 Endovascular Grafts
2.2.1 Indications for Use of Endovascular Grafts
2.2.2 Procedure Volumes for Endovascular Grafts
2.2.3 Clinical Status and Outcome Data for Endovascular Grafts
2.3 Iliac Stents
2.3.1 Indications for Use
2.3.2 Procedure Volumes for Iliac Stent Implantation
2.3.3 Outcomes Data and Clinical Status
2.4 Biliary and Hepatic Stents
2.4.1 Indications for Use of Biliary and Hepatic Stents
2.4.2 Biliary Stent and TIPS Procedure Volumes
2.4.3 Patient Outcomes and Clinical Status for Biliary and Hepatic Stents
2.5 Tracheal and Esophageal Stents
2.5.1 Indications for Use of Tracheal and Esophageal Stents
2.5.2 Procedure Volumes for Tracheal and Esophageal Stent Implantation
2.5.3 Clinical Status of Tracheobronchial and Esophageal Stents
2.6 Ureteral Stents
2.6.1 Indications for Use of Ureteral Stents
2.6.2 Procedure Volumes for Ureteral Stent Implants
2.6.3 Clinical Status and Outcome Data for Ureteral Stents
2.7 Carotid Stents
2.7.1 Indications for Use of Carotid Artery Stents
2.7.2 Procedure Volumes for Carotid Artery Stents
2.7.3 Clinical Status and Outcome Data for Carotid Artery Stents
2.8 Renal Artery Stents
2.8.1 Indications for Use of Renal Artery Stents
2.8.2 Procedure Volumes for Renal Artery Stents
2.8.3 Clinical Status and Outcome Data for Renal Artery Stents
2.9 Prosthetic Vascular Grafts
2.9.1 Trends in Vascular Surgery
2.9.2 Indications for Use of Prosthetic Vascular Grafts
2.9.3 Procedure Volumes for Prosthetic Vascular Grafts
2.9.4 Clinical Status and Outcome Data for Prosthetic Vascular Grafts
2.10 Delivery Methods for Stents and Endovascular Grafts
3. TECHNOLOGY ASSESSMENT AND MARKET ANALYSIS
3.1 Coronary Stent Market Analysis
3.1.1 Existing Coronary Stent Products
3.1.2 Coronary Stent Products Under Development
3.1.3 Coronary Stent Market Forecast
3.1.4 Suppliers' Sales and Market Shares for Coronary Stents
3.1.5 Drivers and Limiters of the Global Coronary Stent Market
3.2 Endovascular Graft Market Analysis
3.2.1 Existing Endovascular Graft Products
3.2.2 Endovascular Graft Products Under Development
3.2.3 Endovascular Graft Market Forecast
3.2.4 Suppliers' Sales and Market Shares for Endovascular Grafts
3.2.5 Endovascular Graft Market Drivers and Limiters
3.3 Iliac Stent Market Analysis
3.3.1 Existing Iliac Stent Products
3.3.2 Development-Stage Iliac and Femoro-Popliteal Stents
3.3.3 Iliac Stent Market Forecast
3.3.4 Suppliers' Sales and Market Shares for Iliac Stents
3.3.5 Iliac Stent Market Drivers and Limiters
3.4 Biliary and Hepatic Stent Market Analysis
3.4.1 Existing Biliary and Hepatic Stent Products
3.4.2 Biliary and Hepatic Stent Products Under Development
3.4.3 Biliary Stent and TIPS Market Forecast
3.4.4 Biliary/TIPS Stent Suppliers' Sales and Market Shares
3.4.5 Drivers and Limiters of the Biliary/TIPS Stent Market
3.5 Tracheal and Esophageal Stent Market Analysis
3.5.1 Tracheal and Esophageal Stent Products
3.5.2 Tracheal and Esophageal Stent Market Forecast
3.5.3 Tracheobronchial and Esophageal Stent Suppliers' Sales and Market Shares
3.5.4 Tracheal and Esophageal Stent Market Drivers and Limiters
3.6 Ureteral Stent Market Analysis
3.6.1 Ureteral Stent Products
3.6.2 Ureteral Stent Market Forecast
3.6.3 Ureteral Stent Suppliers' Sales and Market Shares
3.6.4 Ureteral Stent Market Drivers and Limiters
3.7 Prosthetic Vascular Graft Market Analysis
3.7.1 Existing Prosthetic Vascular Graft Products
3.7.2 Prosthetic Vascular Graft Products Under Development
3.7.3 Prosthetic Vascular Graft Market Forecast
3.7.4 Prosthetic Vascular Graft Suppliers' Sales and Market Shares
3.7.5 Prosthetic Vascular Graft Market Drivers and Limiters
4. EMERGING STENT AND ALTERNATIVE TECHNOLOGIES
4.1 Biodegradable Stents
4.2 Angiogenesis Therapy
4.3 Advances in Minimally Invasive Surgery
4.4 Technologies for the Treatment of In-Stent Restenosis
4.5 Vulnerable Plaque Detection Technologies
4.6 Intravascular Sonotherapy and Cryotherapy
4.7 Carotid Stents
5. COMPETITIVE ANALYSIS
5.1 Market Segmentation and Research and Development Investment Strategies
5.2 Technology Portfolio Analysis
5.3 Marketing and Distribution Strategies
5.4 Key Acquisitions and Partnerships
6. COMPANY PROFILES
6.1 Abbott Laboratories
6.2 Advanced Stent Technologies
6.3 AngioDynamics
6.4 Atrium Medical
6.5 B Braun
6.6 Biotronik
6.7 Blue Medical Devices
6.8 Boston Scientific
6.9 Cook
6.10 Cordis Corporation/Johnson & Johnson
6.11 C.R. Bard
6.12 Edwards Lifesciences
6.13 Guidant
6.14 Hexacath
6.15 JOMED
6.16 Medtronic AVE
6.17 Orbus International
6.18 Sorin Biomedica
6.19 Translumina
6.20 W.L. Gore
References
Company Listing
| Description
|
Catalog No.
|
Pricing
|
| Global Markets for Stents and Vascular Grafts, 2002-2008
|
Report #376
|
$2,995*
|
*outside U.S. add $75. California residents add applicable sales tax
|
|